EMILY DEES: Open Payments
NPI 1831806439 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 93 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $915 · 2025 $1,990
Food & beverage: $1,984Education: $5
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $336 |
| Neurocrine BioSciences, Inc. | 15 | $325 |
| Janssen Pharmaceuticals, Inc | 9 | $240 |
| Lundbeck LLC | 12 | $223 |
| Teva Pharmaceuticals USA, Inc. | 7 | $201 |
| E.R. Squibb & Sons, L.L.C. | 10 | $193 |
| ABBVIE INC. | 11 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Alkermes, Inc. | 3 | $54 |
Products named: FANAPT, INGREZZA, COBENFY, UZEDY, VRAYLAR, ABILIFY ASIMTUFII, SPRAVATO, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
